MedPath

The investigating of the effect of curcumin and zinc co-supplementation on glycemic measurements, lipid profiles, inflammatory and antioxidant biomarkers in pre-diabetic patients

Phase 3
Conditions
Pre-diabetic.
Abnormal glucose tolerance test
R-73.0
Registration Number
IRCT20190902044671N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
84
Inclusion Criteria

both genders
age: 18-50 years (for women 18 years before menopause
individuals with IFG =100-125 (mg/dL), IGT =140-199(mg/dL), or/and HbA1c=% 6.4 -5.7 ,
individuals with BMI=25-35
No use of blood glucose-lowering drugs such as Metformin or Glucophage
individuals with written informed consent from patients

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath